Abstract
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blake D, Weathers F, Nagy L, Kaloupeck D, Klauminzer D, Charney DS, Keane TM (1990). A clinician rating scale for assessing current and lifetime PTSD: the CAPS 1. Behav Ther 18:187–188
Braun P, Greenberg D, Dasenberg H, Lerer B (1990) Core symptoms of posttraumatic stress disorder unimproved by alprozolam treatment. J Clin Psychiatry 51:236–238
Breslau N, Davis GC, Andreski P et al. (1991) Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48:212–218
Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, Saunders WB, Cavenar JO (1990) Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 47:259–266
Davidson JT, Hughes D, Blazer DG, George LK (1991) Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med 21:713–721
Frank JB, Kosten TR, Giller EL, Dan E (1988) A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 145:1289–1291
Helzer JE, Robins LN, McEvoy L (1987) Posttraumatic stress disorder in a general population: finding of the epidemiological catchment area survey. New Engl J Med 317:1630–1634
Horowitz MJ, Wilner NR, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218
Katz R, Lott M, Arbus P, Crocq L, Herlobsen P, Lingjaerde O, Lopez G, Loughrey GC, MacFarlane DJ, McIvor R, Mehlum L, Nugent D, Turner S, Weisaeth L, Yule W (1994/95) Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety 1:169–174
Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL (1991) Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179:366–370
Moller HJ, Wendt G, Waldmeier P (1991) Brofaromine-a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacologic and clinical findings. Pharmacopsychiatry 24:50–54
Montgomery S, Asberg M (1979) A new depression scale designed to be responsive to change. Br J Psychiatry 134:382–388
Reist C, Kauffman DD, Haier RJ, Sangdahl C, DeMet EM, ChiczDeMet A, Nelson JN (1989) A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 146:513–516
Shestatzky M, Greenberg D, Lerer B (1988) A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 24:149–155
Van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994) Fluoxetine treatment in post traumatic stress disorder. J Clin Psychiatry 55:517–522
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baker, D.G., Diamond, B.I., Gillette, G. et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology 122, 386–389 (1995). https://doi.org/10.1007/BF02246271
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246271